EX-16.1 2 ortx-ex161_9.htm EX-16.1 ortx-ex161_9.htm

 

 

Exhibit 16.1

November 13, 2019

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Commissioners:

 

We have read the statements made by Orchard Therapeutics plc on Form 6-K (copy attached), which we understand will be filed with the Securities and Exchange Commission as part of a Report of Foreign Private Issuer on Form 6-K dated November 13, 2019. We agree with the statements concerning our Firm contained therein.

 

Very truly yours,

 

 

/s/ PricewaterhouseCoopers LLP

 

PricewaterhouseCoopers LLP

Reading

United Kingdom

 

 

Attachment

 

PricewaterhouseCoopers LLP, 3 Forbury Place, 23 Forbury Road, Reading, Berkshire, RG1 3JH

T: +44 (0) 118 597 111, F: +44 (0) 1189 383 020, www.pwc.co.uk

 

PricewaterhouseCoopers LLP is a limited liability partnership registered in England with registered number OC303525.  The registered office of

PricewaterhouseCoopers LLP is 1 Embankment Place, London WC2N 6RH.  PricewaterhouseCoopers LLP is authorised and regulated by the Financial Conduct Authority for designated investment business.